MedPath

Trial of Weaning by Synchronized Ventilation

Not Applicable
Completed
Conditions
Neonatal Respiratory Failure
Interventions
Device: Treatment protocol designed to evaluate (SLE 5000 ventilator)
Registration Number
NCT01376544
Lead Sponsor
King's College London
Brief Summary

During assist control ventilation and pressure support ventilation (PSV), the start of ventilator inflation is determined by the start of the infant's inspiratory effort. During PSV, termination of inflation is determined by the level of the infant's inspiratory flow. In a randomized trial, no significant differences were found between assist control and pressure support ventilation with regard to the duration of weaning, time to successful extubation, work of breathing, rate of asynchrony and level of respiratory muscle strength.

Detailed Description

Objectives: To test the hypothesis that the duration of weaning would be shorter using assist control ventilation (ACV) rather than pressure support ventilation (PSV). To determine if any differences in the duration of weaning reflected differences in the work of breathing, the rate of asynchrony or the level of respiratory muscle strength.

Patients and methods: Thirty-six infants, median gestational age 29 (range 24 to 39) weeks, were randomized to weaning by either ACV or PSV. The duration of weaning was recorded. At baseline (study entry), 24 hours after entering the study and immediately prior to extubation, the work of breathing was assessed by measuring the transdiaphragmatic pressure time product (PTPdi), thoracoabdominal asynchrony (TAA) was assessed using respiratory inductance plethysmography and respiratory muscle strength measured by recording the maximal inspiratory pressure produced during an airway occlusion during crying (Pimax). Immediately prior to extubation, the level of active expiration was also assessed.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
36
Inclusion Criteria
  • Ventilated neonates less than 14 days of age
Exclusion Criteria
  • Congenital heart disease, hypoxic ischaemic encephalopathy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Assist control ventilationTreatment protocol designed to evaluate (SLE 5000 ventilator)Assist control ventilation
Pressure support ventilationTreatment protocol designed to evaluate (SLE 5000 ventilator)-
Primary Outcome Measures
NameTimeMethod
To determine which mode of ventilation was associated with a shorter duration of weaning.Up to 28 days after birth
Secondary Outcome Measures
NameTimeMethod
Change in Work of breathing thoraco-abdominal asynchrony respiratory muscle strengthBaseline, 24 hours and prior to extubation

Trial Locations

Locations (1)

Neonatal Intensive Care Unit

🇬🇧

London, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath